Treatment with Adalimumab (Humira ®) and intravenous immunoglobulin improves pregnancy rates in women undergoing IVF

American Journal of Reproductive Immunology

Volumn 61, Issue 2, 2009, Pages 113-120

  Winger, Edward E ^a   Reed, Jane L ^a   Ashoush, Sherif ^b   Ahuja, Sapna ^b   El Toukhy, Tarek ^b   Taranissi, Mohamed ^b  

^a Laboratory for Reproductive Medicine and Immunology   (United States)

^b Assisted Reproduction and Gynaecology Centre   (United Kingdom)

Author keywords

Heparin; Intravenous immunoglobulin; Th1 Th2 ratio; Tumor necrosis factor ; Tumor necrosis factor inhibitor

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; CD3 ANTIGEN; CD56 ANTIGEN; ENOXAPARIN; IMMUNOGLOBULIN;

ADULT; ARTICLE; BIRTH RATE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; EMBRYO; FEMALE; FERTILIZATION IN VITRO; FETUS HEART RATE; HUMAN; INFERTILITY; LIVE BIRTH; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MONOTHERAPY; PREGNANCY OUTCOME; PREGNANCY RATE; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; REPRODUCTIVE SUCCESS; TH1 CELL; TH2 CELL; TREATMENT RESPONSE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CYTOKINES; FEMALE; FERTILIZATION IN VITRO; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFERTILITY, FEMALE; PREGNANCY; PREGNANCY RATE;

EID: 58249141891     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2008.00669.x     Document Type: Article

References (42)

1. Kaider AS, Kaider BD, Janowicz PB, Roussev RG: Immunodiagnostic evaluation in women with reproductive failure. Am J Reprod Immunol 1999; 42:335-346.
2. Billingham RE, Brent I, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606.
3. Mosmann TR, Sad S: The expanding universe of T cell subsets-Th1, Th2 and more. Immunol Today 1996; 17:138-146.
4. Lin H, Mossmann TR, Guilbert L, Tuntipopat L, Wegmann TG: Synthesis of T Helper -2 cytokines at the maternal fetal interface. J Immunol 1993; 151:4568.
5. Hill JA, Polgar K, Anderson DJ: T-helper 1 type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 1995; 273:1933-1936.
6. Krishnan L, Guilbert LJ, Wegmann TG, Belosevic M, Mossmann TR: Helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorption: Correlation with increased IFN-γ and TNF and reduced IL-10 production by placental cells. J Immunol 1996; 156:653-662.
7. Beer AE: Idiopathic infertility, implantation failure, recurrent pregnancy loss. Presented at the Philippine Obstetrical and Gynecological Society Annual Convention, Manila, Nov 15, 2000.
8. Beer AE: Lecture presented before the British Fertility Society and the Association of Clinical Embryologists at Nottingham, Jan 7, 2002.
9. Coulam CB, Goodman C, Roussev RG, Thomasen EJ, Beaman KD: Systemic CD56+ cells can predict pregnancy outcome. Am J Reprod Immunol 1995; 33:40-46.
10. Beer AE, Kwak JY, Ruiz JE: Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am J Reprod Immunol 1996; 35:376-382.
11. Kwak JY, Beaman KD, Gilman-Sachs A, Ruiz JE, Schewitz D, Beer AE: Up-regulated expression of CD56+, CD56+/CD16+, and CD19+cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses. Am J Reprod Immunol 1995; 34: 93-99.
12. Beer AE, Kwak JYH: Intravenous immunoglobulin G (IVIG) dream or reality? Presented at ART Symposium. Maui, HA, 1997.
13. Kwak JY, Gilman-Sachs A, Moretti M, Beaman KD, Beer AE: Natural killer cell cytotoxicity and paternal lymphocyte immunization in women with recurrent spontaneous abortions. Am J Reprod Immunol 1998; 40:352-358.
14. Gilman-Sachs A, DuChateau BK, Aslakson CJ, Wohlgemuth GP, Kwak JY, Beer AE, Beaman KD: Natural Killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions. Am J Reprod Immunol 1999; 41:99-105.
15. Beer AE: Th-1/Th-2 natural killer cell activation systemically and locally in the endometrium and therapeutic options. Am J Reprod Immunol 2001; 45:23.
16. Mangubat CP, Thaker PP, Cavalcante M, Kwak-Kim JYH, Beer AE: Etanercept and immune treatment in multiple IVF failures. Am J Reprod Immunol 2001; 45:24.
17. Clark DA, Coulam CB, Stricker RB: Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). J Assist Reprod Genet 2006; 23:1-13.
18. Coulam CB, Krysa LW, Bustillo M: Intravenous immunoglobulin for in-vitro fertilization failure. Hum Reprod 1994; 9: 2265-2269.
19. Scher J, Salazar C: Clinical experience with IVIg Rx in patients with prior failed IVF pregnancies: Report of 30 consecutive patients. Am J Reprod Immunol 2000; 44:121-124.
20. Yamada H, Morikawa M, Furuta I: Intravenous immunoglobulin treatment in women with recurrent abortions: Increased cytokine levels and reduced Th1/Th2 lymphocyte ratio in peripheral blood. Am J Reprod Immunol 2003; 49:84.
21. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA: Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J Immunol 1998; 160:545-549.
22. Foerster K, He W, Manuel J, Bartczak A, Liu M, Markert UR, Levy GA, Clark DA: LPS-induced occult loss in mice requires FGL2. Am J Reprod Immunol 2007; 58:524-529.
23. Winger EE, Reed JL: Treatment with tumor necrosis factor inhibitors and intravenous immunoglobulin improves live birth rates in women with recurrent spontaneous abortion. Am J Reprod Immunol 2008; 60:8-16.
24. Chaouat G: The TS1/Th2 paradigm: still important in pregnancy? Semin Immunopathol 2007; 29:95-113.
25. Croy BA, Esadeg S, Chantakru S, van den Heuvel M, Paffaro VA, He H, Black GP, Ashkar AA, Kiso Y, Zhang J: Update on pathways regulating the activation of uterine Natural Killer cells, their interactions with decidual spiral arteries and homing of their precursors to the uterus. J Reprod Immunol 2003; 59:175-191.
26. Ashkar AA, Black GP, Wei H, Liang L, Head JR, Croy BA: Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J Immunol 2003; 17:2937-2944.
27. Sargent IL, Borzychowski AM, Redman CWG: NK cells and human pregnancy-an inflammatory view. Trends Immunol 2006; 27:399-404.
28. Hiby SE, Walkeer JJ, O'Shaughnessy KM, Redman CW, Carrington M, Trowsdale A, Moffett A: Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004; 200:957-965.
29. Yamada H, Shimada S, Morikawa M, Iwabuchi K, Kishi R, Onoé K, Minakami H: Divergence of natural killer cell receptor and related molecule in the decidua from sporadic miscarriage with normal chromosome karyotype. Mol Hum Reprod 2005; 11:451-457.
30. Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D, Keramitsoglou T, Darlamitsou A, Tsekoura C, Papadimitropoulos M, Lepage V, Balafoutas C, Stavropoulos-Giokas C: Natural Killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49:183-191.
31. Hesslein DG, Takaki R, Hermiston ML, Weiss A, Lanier LL: Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production. Proc Natl Acad Sci USA 2006; 103:7012-7017.
32. Kopcow HD, Allan DSJ, Chen X, Rybalov B, Andzelm MM, Ge BG, Strominger JL: Human decidual NK cells form immature activating synapses and are not cytolytic. PNAS 2005; 102:15563-15568.
33. Vacca P, Pietra G, Falco M, Bottino C, Moretta A, Moretta L, Mingari MC: Phenotypic and functional characterization of human decidual natural killer cells. Clin Immunol 2008; 127(Suppl.):S158.
34. Koga K, Aldo P, Peng B, Fill S, Cardenas G, Mor G: Abstract 42: Activation of TLR-3 in the trophoblast is associated with preterm delivery. Am J Reprod Immunol 2008; 59:463-517.
35. Kwak-Kim JYH, Chung-Bang HS, Ng SC, Ntrivalas EI, Mangubat CP, Beaman KD, Beer AE, Gilman-Sachs A: Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18:767-773.
36. Kwak-Kim JYH, Gilman-Sachs A, Kim CE: T helper 1 and 2 immune responses in relationship to pregnancy, nonpregnancy, recurrent spontaneous abortions and infertility of repeated implantation failures. Chem Immunol Allergy 2005; 88:64-79.
37. http://www.fda.gov/CDER/foi/label/2002/adalabb123102LB.htm#cp. Humira product insert, accessed, 1 June 2008.
38. Fukui A, Fujii S, Yamaguchi E, Kimura H, Sato S, Saito Y: Natural killer cell subpopulations and cytotoxicity for infertile patients undergoing in vitro fertilization. Am J Reprod Immunol 1999; 41:413-422.
39. Winger EE: CD57+ cells and recurrent spontaneous abortion. Am J Reprod Immunol 2007; 58:311-314.
40. Van den Heuvel MJ, Peralta CG, Hatta K, Han VK, Clark DA: Decline in number of elevated blood CD3(+) CD56(+) NKT cells in response to intravenous immunoglobulin treatment correlates with successful pregnancy. Am J Reprod Immunol 2007; 58:447-459.
41. Blois M, Kämmerer U, Soto CA, Tomettenl M, Shaikly V, Barrientos G, Jurd R, Rukavina D, Thomson AW, Klapp B, Fernández N, Arck PC: Dendritic cells (DC): Key to fetal tolerance? BOR Papers in Press, 2007; 00:000-000. doi:.
42. H17 cells inAdevelopment: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-348.